Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective US claims study. [electronic resource]
- Current medical research and opinion 02 2020
- 261-270 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1473-4877
10.1080/03007995.2019.1690440 doi
Adolescent Adult Crotonates--therapeutic use Female Fingolimod Hydrochloride--therapeutic use Humans Hydroxybutyrates Male Middle Aged Multiple Sclerosis--drug therapy Nitriles Recurrence Retrospective Studies Time-to-Treatment Toluidines--therapeutic use Treatment Failure United States Young Adult